Prometheus fires pellets for colon treatment
Prometheus Laboratories has initiated US Phase II trials of Colal-Pred, a treatment for ulcerative colitis which uses Alizyme's drug delivery technology to provide therapeutics solely to the colon.
Archives for May 25, 2008
Australian industry eyeing clinical trial ascent
Australia's clinical trial industry is taking steps to promote itself further on the world stage, along with the forging of closer ties with the budding Asia-Pacific region.
Generex set to start trials of metformin gum
Buccal drug delivery specialist Generex Biotechnology reports that the production of its chewing gum-based metformin, MetControl, has been completed ahead of forthcoming trials in patients with diabetes.
Catalent reports profit dip; FDA probes sterile site
Catalent Pharma Solutions has reported a profit drop in its latest financial results, completed the sale of one of its businesses, and is undergoing regulatory scrutiny over the overall control and management of quality systems at one of its sterile...